<p>Correlations with pharmacokinetic parameters were performed in patients (n = 13) and controls (n = 5) while correlation with prognostic factors were only performed in patients (n = 13). Patients 3 and 4 excluded because of interacting medication (see text). AUC<sub>0–∞</sub> = area under the curve time zero to infinity, iv = intravenous, po = oral administration.</p
BACKGROUND & AIMS: Ursodeoxycholic acid (UDCA) exerts anticholestatic, antifibrotic and antiprol...
<p>Correlation between serum 25(OH)D levels and hemodynamic parameters in PH patients.</p
<p>Correlations between clinical outcomes and metabolites/metabolite ratios in ALS.</p
<p>Relationship between the serum bile acid or chenodeoxycholic acid concentration with bioavailabil...
Correlation coefficients between indicators of bile acid disequilibrium and markers of NAFLD severit...
Additional file 1: Table S1. Correlation of serum bile acids and bilirubin in all patients. Table S2...
Hepatobilary diseases cause the accumulation of toxic bile acids (BA) in the liver, blood, and other...
<p>There were significant correlations between serum ChE activity and the above parameters in all po...
A. Spearman correlations analysis of metabolites and clinical tests. SpO2 = Oxygen saturation; LDH =...
<p>(A) The plot depicts median log<sub>2</sub> fold changes of bilirubin (Bili), and unconjugated as...
<p>Mean serum total, primary and secondary bile acid concentration profiles over 12(left) and weight...
<p>Correlations of biomarkers with clinical and echocardiographic parameters.</p
<p>Bile from PSC patients showed a marked increase in biliary protein content. (<b>A</b>) Box plots ...
BACKGROUND & AIMS: Ursodeoxycholic acid (UDCA) exerts anticholestatic, antifibrotic and antiprol...
BACKGROUND & AIMS: Ursodeoxycholic acid (UDCA) exerts anticholestatic, antifibrotic and antiprol...
BACKGROUND & AIMS: Ursodeoxycholic acid (UDCA) exerts anticholestatic, antifibrotic and antiprol...
<p>Correlation between serum 25(OH)D levels and hemodynamic parameters in PH patients.</p
<p>Correlations between clinical outcomes and metabolites/metabolite ratios in ALS.</p
<p>Relationship between the serum bile acid or chenodeoxycholic acid concentration with bioavailabil...
Correlation coefficients between indicators of bile acid disequilibrium and markers of NAFLD severit...
Additional file 1: Table S1. Correlation of serum bile acids and bilirubin in all patients. Table S2...
Hepatobilary diseases cause the accumulation of toxic bile acids (BA) in the liver, blood, and other...
<p>There were significant correlations between serum ChE activity and the above parameters in all po...
A. Spearman correlations analysis of metabolites and clinical tests. SpO2 = Oxygen saturation; LDH =...
<p>(A) The plot depicts median log<sub>2</sub> fold changes of bilirubin (Bili), and unconjugated as...
<p>Mean serum total, primary and secondary bile acid concentration profiles over 12(left) and weight...
<p>Correlations of biomarkers with clinical and echocardiographic parameters.</p
<p>Bile from PSC patients showed a marked increase in biliary protein content. (<b>A</b>) Box plots ...
BACKGROUND & AIMS: Ursodeoxycholic acid (UDCA) exerts anticholestatic, antifibrotic and antiprol...
BACKGROUND & AIMS: Ursodeoxycholic acid (UDCA) exerts anticholestatic, antifibrotic and antiprol...
BACKGROUND & AIMS: Ursodeoxycholic acid (UDCA) exerts anticholestatic, antifibrotic and antiprol...
<p>Correlation between serum 25(OH)D levels and hemodynamic parameters in PH patients.</p
<p>Correlations between clinical outcomes and metabolites/metabolite ratios in ALS.</p